The First Faculty of Medicine of Charles University is one of five medical faculties of Charles University, Prague, Czech Republic. Founded in 1348 at the same time as the university itself, it is the oldest medical faculty in Central Europe and the 11th oldest medical institution in the world.

During the past decade, Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" #1 sponsor was "Charles University, Czech Republic" with 7 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Gustave Roussy, Cancer Campus, Grand Paris" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Lymphoma Trials Office" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" are "Motor Activity" (5 trials), "Diabetes Mellitus, Type 1" (2 trials), "Leukemia" (2 trials), "Lung Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" in a lesser frequency.

Most popular intervention types in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" are "Diagnostic Test" (5 trials), "Drug" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Box and Block Test" (2 trials), "Nine Hole Peg Test" (2 trials), "Purdue Pegboard Test" (2 trials), "CHOP regimen" (1 trials) and "Continuous Glucose Monitoring Dexcom G5 and G6 system (real-time continuous glucose monitoring)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".